SCHEMBL4928746

SCHEMBL4928746

Cc1cc(N(C)C)cc(N[C@H]2CC[C@@H](NC(=O)c3cccc(C(F)(F)F)c3)CC2)n1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 10/20 0.60
ADRA2A P08913 3/20 0.60
PHGDH O43175 2/20 0.56
ADRA1A P35348 2/20 0.56
HRH1 P35367 2/20 0.56
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
HTR2B P41595 1/20 0.48
CCR2 P41597 3/20 0.48
KDM4E B2RXH2 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
GFER P55789 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
BTK Q06187 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47
TAS1R2 Q8TE23 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928750 1.00 MCHR1 (0.60) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL4263772 0.89 MCHR1 (0.60) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL4263766 0.89 MCHR1 (0.60) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL4271990 0.85 MCHR1 (0.60) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL4271984 0.85 MCHR1 (0.60) MCHR1ADRA2APHGDHADRA1AHRH1
Hydrochloric Acid SCHEMBL4255662 0.84 MCHR1 (0.59) MCHR1ADRA2APHGDHADRA1AHRH1
Hydrochloric Acid SCHEMBL4255660 0.84 MCHR1 (0.59) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL6464945 0.83 MCHR1 (0.82) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL6464940 0.83 MCHR1 (0.82) MCHR1ADRA2APHGDHADRA1AHRH1
SCHEMBL4932083 0.82 MCHR1 (0.68) MCHR1ADRA2AADRA1AHRH1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US claimed
WO-2006035967-A1 PYRIDINE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR TREATING DISEASES RELATED TO MCH RECEPTOR TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO claimed
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor MCHR1, GPR119, MCHR2 MCHR1 1/4885ADRA2A 133/4885PHGDH 2639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.